Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy

1. García-Girón, C.
2. Palomo, A.G.
3. López, C.A.
4. Carbonero, A.L.
5. Ureña, M.M.
6. Cebrián, E.A.
7. Galíndez, R.B.
8. Yustos, M.A.
9. Gallego, J.A.